Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Canada
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
Molecular Weight | 236.23 g/mol |
---|---|
Molecular Formula | C10H12N4O3 |
XLogP3 | -1.2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 236.09094026 g/mol |
Monoisotopic Mass | 236.09094026 g/mol |
Topological Polar Surface Area | 88.7 A^2 |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 348 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 6 | |
---|---|
Drug Name | Didanosine |
Drug Label | Didanosine delayed-release capsules are an enteric-coated formulation of didanosine, (ddl), a synthetic purine nucleoside analogue active against the Human Immunodeficiency Virus (HIV). Didanosine delayed-release capsules, containing enteric-coated p... |
Active Ingredient | Didanosine |
Dosage Form | Capsule, delayed rel pellets; Tablet, for suspension; For solution |
Route | Oral |
Strength | 200mg; 250mg; 100mg; 125mg; 150mg; 10mg/ml; 400mg |
Market Status | Prescription |
Company | Mylan Pharms; Aurobindo; Aurobindo Pharma; Barr |
2 of 6 | |
---|---|
Drug Name | Videx |
PubMed Health | Didanosine (By mouth) |
Drug Classes | Antiretroviral Agent |
Drug Label | VIDEX is a brand name for didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. Didanosine is available as VIDEX, a Pediatric Powder for Oral Solution [see How Supplied/Storage and Handling (16)] and as VIDEX EC Delayed-Re... |
Active Ingredient | Didanosine |
Dosage Form | For solution |
Route | Oral |
Strength | 10mg/ml |
Market Status | Prescription |
Company | Bristol Myers Squibb |
3 of 6 | |
---|---|
Drug Name | Videx ec |
PubMed Health | Didanosine (By mouth) |
Drug Classes | Antiretroviral Agent |
Drug Label | VIDEX EC is the brand name for an enteric-coated formulation of didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. VIDEX EC Delayed-Release Capsules, containing enteric-coated beadlets, are available for oral administrati... |
Active Ingredient | Didanosine |
Dosage Form | Capsule, delayed rel pellets |
Route | Oral |
Strength | 200mg; 250mg; 125mg; 400mg |
Market Status | Prescription |
Company | Bristol Myers Squibb |
4 of 6 | |
---|---|
Drug Name | Didanosine |
Drug Label | Didanosine delayed-release capsules are an enteric-coated formulation of didanosine, (ddl), a synthetic purine nucleoside analogue active against the Human Immunodeficiency Virus (HIV). Didanosine delayed-release capsules, containing enteric-coated p... |
Active Ingredient | Didanosine |
Dosage Form | Capsule, delayed rel pellets; Tablet, for suspension; For solution |
Route | Oral |
Strength | 200mg; 250mg; 100mg; 125mg; 150mg; 10mg/ml; 400mg |
Market Status | Prescription |
Company | Mylan Pharms; Aurobindo; Aurobindo Pharma; Barr |
5 of 6 | |
---|---|
Drug Name | Videx |
PubMed Health | Didanosine (By mouth) |
Drug Classes | Antiretroviral Agent |
Drug Label | VIDEX is a brand name for didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. Didanosine is available as VIDEX, a Pediatric Powder for Oral Solution [see How Supplied/Storage and Handling (16)] and as VIDEX EC Delayed-Re... |
Active Ingredient | Didanosine |
Dosage Form | For solution |
Route | Oral |
Strength | 10mg/ml |
Market Status | Prescription |
Company | Bristol Myers Squibb |
6 of 6 | |
---|---|
Drug Name | Videx ec |
PubMed Health | Didanosine (By mouth) |
Drug Classes | Antiretroviral Agent |
Drug Label | VIDEX EC is the brand name for an enteric-coated formulation of didanosine, USP, a synthetic purine nucleoside analogue active against HIV-1. VIDEX EC Delayed-Release Capsules, containing enteric-coated beadlets, are available for oral administrati... |
Active Ingredient | Didanosine |
Dosage Form | Capsule, delayed rel pellets |
Route | Oral |
Strength | 200mg; 250mg; 125mg; 400mg |
Market Status | Prescription |
Company | Bristol Myers Squibb |
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
42
PharmaCompass offers a list of Didanosine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Didanosine manufacturer or Didanosine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Didanosine manufacturer or Didanosine supplier.
PharmaCompass also assists you with knowing the Didanosine API Price utilized in the formulation of products. Didanosine API Price is not always fixed or binding as the Didanosine Price is obtained through a variety of data sources. The Didanosine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine, including repackagers and relabelers. The FDA regulates Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine supplier is an individual or a company that provides Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine active pharmaceutical ingredient (API) or Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine finished formulations upon request. The Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine suppliers may include Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine API manufacturers, exporters, distributors and traders.
click here to find a list of Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine DMF (Drug Master File) is a document detailing the whole manufacturing process of Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine active pharmaceutical ingredient (API) in detail. Different forms of Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine DMFs exist exist since differing nations have different regulations, such as Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine DMF submitted to regulatory agencies in the US is known as a USDMF. Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine USDMF includes data on Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine suppliers with USDMF on PharmaCompass.
A Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine CEP of the European Pharmacopoeia monograph is often referred to as a Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine Certificate of Suitability (COS). The purpose of a Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine to their clients by showing that a Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine CEP has been issued for it. The manufacturer submits a Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine CEP holder for the record. Additionally, the data presented in the Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine DMF.
A Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine suppliers with CEP (COS) on PharmaCompass.
A Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine written confirmation (Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine WC) is an official document issued by a regulatory agency to a Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine manufacturer, verifying that the manufacturing facility of a Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine APIs or Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine finished pharmaceutical products to another nation, regulatory agencies frequently require a Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine WC (written confirmation) as part of the regulatory process.
click here to find a list of Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine suppliers with NDC on PharmaCompass.
Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine GMP manufacturer or Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine GMP API supplier for your needs.
A Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine CoA (Certificate of Analysis) is a formal document that attests to Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine's compliance with Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine specifications and serves as a tool for batch-level quality control.
Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine CoA mostly includes findings from lab analyses of a specific batch. For each Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine EP), Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine USP).